Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-50
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

Primary ciliary dyskinesia (PCD) is a rare disease, caused by impairment of the motile cilia. Patients present with chronic upper and lower respiratory tract infections. The therapy is mainly supportive and based on that of cystic fibrosis. Chest physiotherapy is one of the cornerstones of the therapy, however the influence of chest physiotherapy on lung function (short term and long term) is not clear. For interpretation of longitudinal lung function data it is important to examine the short time effect of chest physiotherapy. We hypothesize that a session of chest physiotherapy improves lung function and that thus lung function tests must be performed in a standardized way.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Primary ciliary dyskinesia

able to perform spirometry and MBW (>6 years)

Disqualifiers

acute exacerbation

Trial design

Design model

Single group

Treatments tested in this trial

  • Chest physiotherapy

    Procedure/Surgery

    20 minutes of chest physiotherapy by physiotherapist

Treatment groups

29 Participants
are divided into 1 treatment group
Group A: chest physiotherapyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Difference in FEV1 before and after treatment

Lung function will be performed before a session of chest physiotherapy, and repeated 30 minutes after a chest physiotherapy session of 20 minutes with airway clearance techniques and use of PEP mask

Time frame
30 minutes

Secondary outcomes

1

Difference in LCI before and after chest physiotherapy

Multiple Breath Washout (MBW) will be performed before and 30 min after a session of chest physiotherapy. The difference in LCI (lung clearance index) will be used as secondary outcome.

Time frame
30 minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.